Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Lisa Gill
JPMorgan Chase & Co, Research Division

Good afternoon, and welcome. My name is Lisa Gill and I head healthcare services here at JPMorgan. It is with great pleasure this afternoon that I have with us Teladoc Health. Presenting for Teladoc Health is CEO, Chuck Divita. Post Chuck’s presentation, we will have a little fireside chat here, okay? So, Chuck?

Charles Divita
CEO & Director

Great. Thanks, and good afternoon, everyone. Hopefully, you can hear okay with this mic. As Lisa said, I’m Chuck Divita, the CEO of Teladoc Health. Really appreciate the opportunity to be here and also for you attending the session. I’m going to provide a company overview and talk about our 2 main segments. Also how we see the role we play in terms of addressing some of the key challenges in health care. I’m going to talk about a bit our 2025, our priorities we set in early 2025, and the progress we’ve made there, as well as our areas of focus in 2026, and I’m going to give a few examples of what we’ve got going on. And then I’ll wrap with some closing comments, and then we’ll move to Q&A. And I have to do the slides, too. Okay.

As you may know, the company has really been a pioneer in terms of the adoption and scaling of virtual care. Really over the 20-year period that the company has been around and really established a leading global position in what we do. We deliver and we orchestrate care across virtual care, chronic condition management, and mental health. And we leverage